SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Parkin Protein

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-prkn-protein
Related Entities
PRKNPROTEIN
Metadata
slugproteins-prkn-protein
entity_typeprotein
kg_node_idPRKNPROTEIN
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (782)
see_also📖Antibody Therapy in Neurodegeneration80%
see_also📖Axon Guidance Pathways in Neurodegeneration80%
see_also📖Convergent Pathways in Neurodegeneration80%
see_also📖COVID-19 Neurodegeneration Mechanism80%
see_also📖Down Syndrome Neurodegeneration Pathway80%
see_also📖Dystrophic Neurites in Neurodegeneration80%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration80%
see_also📖Endosomal Sorting Defects in Neurodegeneration80%
see_also📖Galectin-3 Mechanism in Neurodegeneration80%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration80%
see_also📖HMGB1 Signaling in Neurodegeneration80%
see_also📖IL-1 Signaling Pathway in Neurodegeneration80%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration80%
see_also📖Microglial Priming Pathway in Neurodegeneration80%
see_also📖Neural Circuit Disruption in Neurodegeneration80%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration80%
see_also📖Retinal Degeneration Pathway in Neurodegeneration80%
see_also📖Senescent Cell Clearance in Neurodegeneration80%
see_also📖Sex Differences in Neurodegeneration80%
see_also📖Therapeutic Targets in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St80%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime80%
see_also📖Neuroimaging for Parkinsonian Syndromes (NCT03872102)80%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration80%
see_also📖Exosomal Biomarkers in Neurodegeneration80%
see_also📖Exosomal miR-155 in Neurodegeneration80%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration80%
see_also📖Liquid Biopsy in Neurodegeneration80%
see_also📖Metabolomic Biomarkers in Neurodegeneration80%
see_also📖Neuroimaging Biomarkers for Neurodegeneration80%
see_also📖Synaptic Biomarkers in Neurodegeneration80%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and80%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl80%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 80%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)80%
see_also📖China Neurodegeneration Epidemiology80%
see_also📖DALY Methodology — Neurodegeneration80%
see_also📖Disease Progression & Staging in Neurodegeneration80%
see_also📖Economic Burden — Neurodegeneration80%
see_also📖European Neurodegeneration Epidemiology80%
see_also📖Familial vs Sporadic Neurodegeneration Comparison80%
see_also📖Global Neurodegeneration Epidemiology80%
see_also📖India Neurodegeneration Epidemiology80%
see_also📖Japan Neurodegeneration Epidemiology80%
see_also📖Manganese-Related Neurodegeneration (Manganism)80%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison80%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr80%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 80%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)80%
see_also📖Potential Impact Measures — Neurodegeneration80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)80%
see_also📖Sleep Disorders in Neurodegeneration80%
see_also📖US Neurodegeneration Epidemiology80%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread80%
see_also📖acetylcholine-signaling-neurodegeneration80%
see_also📖Advanced Glycation End Products in Neurodegeneration80%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 80%
see_also📖Amylin Signaling in Neurodegeneration80%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration80%
see_also📖Autosis Pathway in Neurodegeneration80%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration80%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain80%
see_also📖CaMKII Signaling Pathway in Neurodegeneration80%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration80%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration80%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration80%
see_also📖Cholinergic System Dysfunction in Neurodegeneration80%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat80%
see_also📖Neural Circuits in Neurodegeneration80%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration80%
see_also📖Computational Disease Models for Neurodegeneration80%
see_also📖Copper Homeostasis in Neurodegeneration80%
see_also📖Diffusion MRI (DTI) in Neurodegeneration80%
see_also📖Digital Phenotyping in Neurodegeneration80%
see_also📖Endocannabinoid System in Neurodegeneration80%
see_also📖Endothelin Signaling Pathway in Neurodegeneration80%
see_also📖epigenetics-neurodegeneration80%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration80%
see_also📖FA2H-Associated Neurodegeneration Pathway80%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration80%
see_also📖Gangliosides in Neurodegeneration80%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration80%
see_also📖GDNF Signaling Pathway in Neurodegeneration80%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration80%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration80%
see_also📖Glycosylation in Neurodegeneration80%
see_also📖Hippocampal Neurogenesis in Neurodegeneration80%
see_also📖Histone Modification Pathways in Neurodegeneration80%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration80%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration80%
see_also📖Integrated Stress Response in Neurodegeneration80%
see_also📖interleukin-6-signaling-neurodegeneration80%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration80%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 80%
see_also📖Kidney-Brain Neurodegeneration Axis80%
see_also📖Lipid Dysregulation in Neurodegeneration80%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration80%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration80%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration80%
see_also📖Metal Homeostasis in Neurodegeneration80%
see_also📖MicroRNA Dysfunction in Neurodegeneration80%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration80%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration80%
see_also📖Mitochondrial Fusion in Neurodegeneration80%
see_also📖Molecular Chaperones in Neurodegeneration80%
see_also📖mTOR Signaling in Neurodegeneration80%
see_also📖mTOR Signaling Pathway in Neurodegeneration80%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N80%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati80%
see_also📖Neuronal Hyperexcitability in Neurodegeneration80%
see_also📖Neuropil Threads in Neurodegeneration80%
see_also📖Neurotensin Signaling in Neurodegeneration80%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration80%
see_also📖NF-kB Signaling Pathway in Neurodegeneration80%
see_also📖Nitric Oxide Signaling in Neurodegeneration80%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration80%
see_also📖Neuropeptide Y Signaling in Neurodegeneration80%
see_also📖NRF2 Signaling Pathway in Neurodegeneration80%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration80%
see_also📖Orexin Signaling in Neurodegeneration80%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration80%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration80%
see_also📖Paranodal Dysfunction in Neurodegeneration80%
see_also📖Paraptosis in Neurodegeneration80%
see_also📖Parthanatos in Neurodegeneration80%
see_also📖Pericyte Loss in Neurodegeneration80%
see_also📖PKR Pathway in Neurodegeneration80%
see_also📖PPAR Signaling Pathway in Neurodegeneration80%
see_also📖Prion Diseases in Neurodegeneration80%
see_also📖Prion-Like Spread in Neurodegeneration80%
see_also📖Prion Protein Metabolism in Neurodegeneration80%
see_also📖Progesterone Signaling Pathway in Neurodegeneration80%
see_also📖Prognostic Biomarkers in Neurodegeneration80%
see_also📖Protein Aggregation Comparison in Neurodegeneration80%
see_also📖Protein Aggregation Seeds in Neurodegeneration80%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration80%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su80%
see_also📖Purinergic Signaling in Neurodegeneration80%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener80%
see_also📖R-Loop Stress in Neurodegeneration80%
see_also📖RAN Translation in Neurodegeneration80%
see_also📖Ribosome Dysfunction in Neurodegeneration80%
see_also📖RNA Splicing in Neurodegeneration80%
see_also📖RNA-Targeted Therapies in Neurodegeneration80%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a80%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration80%
see_also📖Serotonergic Dysfunction in Neurodegeneration80%
see_also📖Short Chain Fatty Acids in Neurodegeneration80%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration80%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration80%
see_also📖Sleep Dysfunction in Neurodegeneration80%
see_also📖SUMOylation in Neurodegeneration80%
see_also📖synaptic-vesicle-cycling-neurodegeneration80%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration80%
see_also📖T-Cell Dysfunction in Neurodegeneration80%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration80%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration80%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration80%
see_also📖Vagus Nerve Pathway in Neurodegeneration80%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio80%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio80%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen80%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration80%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh75%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 75%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t75%
mentions🧪Temporal Decoupling via Circadian Clock Reset70%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination70%
mentions🧪Netrin-1 Gradient Restoration70%
mentions🧪Smartphone-Detected Motor Variability Correction70%
mentions🧪Purinergic Signaling Polarization Control70%
mentions🧪Mitochondrial-Lysosomal Contact Site Engineering70%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 70%
mentions🧪Circadian-Synchronized Proteostasis Enhancement70%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement70%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%
mentions🧪Ganglioside Rebalancing Therapy70%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering70%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon70%
mentions🧪VCP-Mediated Autophagy Enhancement70%
mentions🧪Senescent Cell Mitochondrial DNA Release70%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption70%
mentions🧪Mitochondrial RNA Granule Rescue Pathway70%
mentions🧪Multi-Modal Stress Response Harmonization70%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu70%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc70%
mentions🧪CYP46A1 Overexpression Gene Therapy70%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade70%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition70%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho70%
mentions🧪Noradrenergic-Tau Propagation Blockade70%
mentions🧪Adenosine-Astrocyte Metabolic Reset70%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho70%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors70%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations70%
mentions🧪Quantum Coherence Disruption in Cellular Communication70%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy70%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics70%
mentions🧪Extracellular Vesicle Biogenesis Modulation70%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes70%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem70%
mentions🧪Complement C1q Subtype Switching70%
mentions🧪Autophagosome Maturation Checkpoint Control70%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener70%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal70%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement70%
mentions🧪PARP1 Inhibition Therapy70%
mentions🧪Ocular Immune Privilege Extension70%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy70%
mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation70%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu70%
mentions🧪Extracellular Matrix Stiffness Modulation70%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation70%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor70%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset70%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading70%
mentions🧪Piezoelectric Nanochannel BBB Disruption70%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis70%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches70%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation70%
mentions🧪Axonal RNA Transport Reconstitution70%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In70%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification70%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%
mentions🧪Orexin-Microglia Modulation Therapy70%
mentions🧪Lysosomal Membrane Repair Enhancement70%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement70%
mentions🧪Lysosomal Calcium Channel Modulation Therapy70%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue70%
mentions🧪Blood-Brain Barrier SPM Shuttle System70%
mentions🧪Mitochondrial Transfer Pathway Enhancement70%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr70%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation70%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto70%
mentions🧪Flotillin-1 Stabilization Compounds70%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization70%
mentions🧪HDAC3-Selective Inhibition for Clock Reset70%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering70%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati70%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th70%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation70%
mentions🧪Transcriptional Autophagy-Lysosome Coupling70%
mentions🧪Digital Twin-Guided Metabolic Reprogramming70%
mentions🧪TREM2-mediated microglial tau clearance enhancement70%
mentions🧪Lysosomal Enzyme Trafficking Correction70%
mentions🧪Circadian Clock-Autophagy Synchronization70%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri70%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai70%
mentions🧪Senescence-Associated Myelin Lipid Remodeling70%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy70%
mentions🧪Senescence-Activated NAD+ Depletion Rescue70%
mentions🧪Competitive APOE4 Domain Stabilization Peptides70%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy70%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy70%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)70%
mentions🧪Vocal Cord Neuroplasticity Stimulation70%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors70%
mentions🧪Microbial Inflammasome Priming Prevention70%
mentions🧪Phase-Separated Organelle Targeting70%
mentions🧪Nucleolar Stress Response Normalization70%
mentions🧪Vagal Afferent Microbial Signal Modulation70%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution70%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy70%
mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection70%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat70%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch70%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming70%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation70%
mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling70%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease70%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease70%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers70%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime70%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di70%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI70%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451670%
see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)70%
see_also📖Alzheimer's Disease Mechanism Index70%
see_also📖APOE4 and Alzheimer's Disease Risk70%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease70%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058265%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06765%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer65%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 65%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC65%
see_also📖Master Screening Study to Determine Individuals With Potenti65%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A65%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease65%
see_also📖Endolysosomal Pathway in Alzheimer's Disease65%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa65%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease65%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ65%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease65%
see_also📖Sporadic Alzheimer's Disease Pathway65%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway65%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's65%
related🧪Temporal Decoupling via Circadian Clock Reset63%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination63%
related🧪Netrin-1 Gradient Restoration63%
related🧪Smartphone-Detected Motor Variability Correction63%
related🧪Purinergic Signaling Polarization Control63%
related🧪Mitochondrial-Lysosomal Contact Site Engineering63%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 63%
related🧪Circadian-Synchronized Proteostasis Enhancement63%
related🧪HSP90-Tau Disaggregation Complex Enhancement63%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer63%
related🧪Ganglioside Rebalancing Therapy63%
related🧪Mitochondrial SPM Synthesis Platform Engineering63%
related🧪CX43 hemichannel engineering enables size-selective mitochon63%
related🧪VCP-Mediated Autophagy Enhancement63%
related🧪Senescent Cell Mitochondrial DNA Release63%
related🧪SASP-Mediated Cholinergic Synapse Disruption63%
related🧪Mitochondrial RNA Granule Rescue Pathway63%
related🧪Multi-Modal Stress Response Harmonization63%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu63%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc63%
related🧪CYP46A1 Overexpression Gene Therapy63%
related🧪Enteric Nervous System Prion-Like Propagation Blockade63%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition63%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho63%
related🧪Noradrenergic-Tau Propagation Blockade63%
related🧪Adenosine-Astrocyte Metabolic Reset63%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho63%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones63%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors63%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations63%
related🧪Quantum Coherence Disruption in Cellular Communication63%
related🧪SIRT6-NAD+ Axis Enhancement Therapy63%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics63%
related🧪Extracellular Vesicle Biogenesis Modulation63%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes63%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem63%
related🧪Complement C1q Subtype Switching63%
related🧪Autophagosome Maturation Checkpoint Control63%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener63%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal63%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement63%
related🧪PARP1 Inhibition Therapy63%
related🧪Ocular Immune Privilege Extension63%
related🧪Hypocretin-Neurogenesis Coupling Therapy63%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation63%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu63%
related🧪Extracellular Matrix Stiffness Modulation63%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation63%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor63%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset63%
related🧪Senescence-Induced Lipid Peroxidation Spreading63%
related🧪Piezoelectric Nanochannel BBB Disruption63%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis63%
related🧪Lipid Droplet Dynamics as Phenotype Switches63%
related🧪Circadian-Synchronized LRP1 Pathway Activation63%
related🧪SASP-Driven Aquaporin-4 Dysregulation63%
related🧪Axonal RNA Transport Reconstitution63%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In63%
related🧪Circadian-Gated Maresin Biosynthesis Amplification63%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming63%
related🧪Orexin-Microglia Modulation Therapy63%
related🧪Lysosomal Membrane Repair Enhancement63%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement63%
related🧪Lysosomal Calcium Channel Modulation Therapy63%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue63%
related🧪Blood-Brain Barrier SPM Shuttle System63%
related🧪Mitochondrial Transfer Pathway Enhancement63%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr63%
related🧪Pharmacological Enhancement of APOE4 Glycosylation63%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto63%
related🧪Flotillin-1 Stabilization Compounds63%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization63%
related🧪HDAC3-Selective Inhibition for Clock Reset63%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering63%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati63%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th63%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation63%
related🧪Transcriptional Autophagy-Lysosome Coupling63%
related🧪Digital Twin-Guided Metabolic Reprogramming63%
related🧪TREM2-mediated microglial tau clearance enhancement63%
related🧪Lysosomal Enzyme Trafficking Correction63%
related🧪Circadian Clock-Autophagy Synchronization63%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri63%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai63%
related🧪Senescence-Associated Myelin Lipid Remodeling63%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy63%
related🧪Senescence-Activated NAD+ Depletion Rescue63%
related🧪Competitive APOE4 Domain Stabilization Peptides63%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy63%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy63%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)63%
related🧪Vocal Cord Neuroplasticity Stimulation63%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors63%
related🧪Microbial Inflammasome Priming Prevention63%
related🧪Phase-Separated Organelle Targeting63%
related🧪Nucleolar Stress Response Normalization63%
related🧪Vagal Afferent Microbial Signal Modulation63%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution63%
related🧪Purinergic P2Y12 Inverse Agonist Therapy63%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection63%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat63%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch63%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming63%
related🧪Trans-Synaptic Adhesion Molecule Modulation63%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling63%
see_also📖Alzheimer's Disease Biomarkers60%
see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease60%
see_also📖Digital Biomarkers for Alzheimer's Disease60%
see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease60%
see_also📖DTI Biomarkers for Alzheimer's Disease60%
see_also📖EEG Biomarkers for Alzheimer's Disease60%
see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease60%
see_also📖Gait Biomarkers for Alzheimer's Disease60%
see_also📖GFAP in Alzheimer's Disease60%
see_also📖Inflammatory Biomarkers in Alzheimer's Disease60%
see_also📖Neurogranin - Alzheimer's Disease Biomarker60%
see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease60%
see_also📖Olfactory Biomarkers for Alzheimer's Disease60%
see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'60%
see_also📖Salivary Biomarkers for Alzheimer's Disease60%
see_also📖Sleep Biomarkers for Alzheimer's Disease60%
see_also📖Synaptic Biomarkers for Alzheimer's Disease60%
see_also📖Tear Film Biomarkers in Alzheimer's Disease60%
see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease60%
see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)60%
see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05660%
see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer60%
see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease60%
see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease60%
see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease60%
see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT060%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di60%
see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636260%
see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea60%
see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease60%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0660%
see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas60%
see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543660%
see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083360%
see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D60%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise60%
see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease60%
see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease60%
see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)60%
see_also📖Masupirdine for Alzheimer's Disease Agitation60%
see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0560%
see_also📖MK-2214 for Early Alzheimer's Disease60%
see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451660%
see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease60%
see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE60%
see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 60%
see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT060%
see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)60%
see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N60%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0660%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI60%
see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)60%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer60%
see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'60%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial60%
see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease60%
see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe60%
see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)60%
see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis60%
see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's60%
see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise60%
see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)60%
see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease60%
see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424160%
see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)60%
see_also📖Siponimod for Alzheimer's Disease (NCT06639282)60%
see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime60%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention60%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'60%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial60%
see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca60%
see_also📖Cholinergic System Degeneration in Alzheimer's Disease60%
see_also📖EEG Microstates in Alzheimer's Disease60%
see_also📖Glymphatic System in Alzheimer's Disease60%
see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease60%
see_also📖Metal Ion Homeostasis in Alzheimer's Disease60%
see_also📖Neuroinflammation in Alzheimer's Disease60%
see_also📖Sex-Specific Mechanisms in Alzheimer's Disease60%
see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease60%
see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 60%
mentions🔬What are the mechanisms underlying what are the mechanisms b60%
mentions🔬What are the mechanisms underlying what are the mechanisms b60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece60%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
mentions🧫AAV-LRRK2 IND-Enabling Study Design60%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
mentions🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
mentions🧫Alpha-Synuclein Seed Amplification Assay Validation60%
mentions🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease60%
mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration60%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka60%
mentions🧫Brainstem Circuit Modulation for PSP60%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
mentions🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
mentions🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%
mentions🧫Combination Therapy Sequencing in Parkinson's Disease60%
mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
mentions🧫DLB Cognitive Fluctuation Mechanism Experiment60%
mentions🧫Genetic Risk Modifiers in DLB Phenotype60%
mentions🧫Tau Co-Pathology in DLB Clinical Heterogeneity60%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%
mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%
mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
mentions🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
mentions🧫Experiment Index60%
mentions🧫Ferroptosis Validation in Parkinson's Disease60%
mentions🧫Gap Junction Dysfunction Validation in Parkinson's Dise60%
mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin60%
mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
mentions🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
mentions🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%
mentions🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design60%
mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre60%
mentions🧫Cytochrome Therapeutics60%
mentions🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
mentions🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
mentions🧫Macroautophagy Dysfunction in PD - Experiment Design60%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
mentions🧫Validation: Membrane-Nucleation in iPSC Neurons60%
mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr60%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress60%
mentions🧫MLCS Quantification in Parkinson's Disease60%
mentions🧫Experiment: Multi-Ethnic PD GWAS60%
mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
mentions🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease60%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
mentions🧫NPH Glymphatic System Interaction Experiment60%
mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
mentions🧫Parkinson's Disease Subtype Classification — Precision 60%
mentions🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
mentions🧫Prion Strain Diversity and Selective Vulnerability in CJD60%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E60%
mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
mentions🧫Protein Aggregation Kinetic Validation Results60%
mentions🧫PSP and CBS Biomarker Validation Study60%
mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec60%
mentions🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
mentions🧫Tau Pathology Initiation Zone Identification60%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%
see_also📖Neurodegeneration60%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial55%
see_also📖APOE4 (Apolipoprotein E4)55%
see_also📖SNCA Gene Variants and Mutations55%
see_also📖SNCA — Alpha-Synuclein Gene Entity Page55%
related🔬What are the mechanisms underlying what are the mechanisms b54%
related🔬What are the mechanisms underlying what are the mechanisms b54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🧫s:** - Temporal analysis showing mitochondrial defects prece54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DLB Cognitive Fluctuation Mechanism Experiment54%
related🧫Genetic Risk Modifiers in DLB Phenotype54%
related🧫Tau Co-Pathology in DLB Clinical Heterogeneity54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Experiment Index54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design54%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr54%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫NPH Glymphatic System Interaction Experiment54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Protein Aggregation Kinetic Validation Results54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫Tau Pathology Initiation Zone Identification54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬RNA binding protein dysregulation across ALS FTD and AD50%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
see_also📖al002-trem2-agonist-alzheimers50%
see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD50%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M50%
see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 50%
see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739250%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas50%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc50%
see_also📖Rigidity in Corticobasal Syndrome50%
see_also📖Multimodal Diagnostic Algorithm for CBS and PSP50%
see_also📖Neuroinflammation in Parkinson's Disease Dementia and D50%
see_also📖Systemic Infection and Tau Pathology Acceleration50%
see_also📖Tau Seeding and Propagation Pathway50%
see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre45%
see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro45%
see_also📖Utilisation of Health Services and Quality of Life in Atypic45%
see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini45%
see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month45%
see_also📖nct0550878945%
see_also📖Long-term Effects of Hearing Intervention on Brain Health in45%
see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co45%
see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr45%
see_also📖remternetug-anti-amyloid-alzheimers45%
see_also📖UPenn Observational Research Repository (NCT04715399)45%
see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi45%
see_also📖APOE2 (Apolipoprotein E2)45%
see_also📖APOE3 (Apolipoprotein E3)45%
see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc45%
see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)45%
see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid45%
see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd45%
see_also📖Physical and Occupational Therapy in Corticobasal Syndrome45%
see_also📖Healthcare Economics and Cost of Illness in Progressive Supr45%
see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O45%
see_also📖SNCA A53T45%
see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro45%
see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%
see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease45%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP45%
see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for45%
see_also📖Braak Staging and Tau Propagation Pathway45%
see_also📖C9orf72 Repeat Expansions in CBS and PSP45%
see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%
see_also📖CBS/PSP Panxoneopathy and Membrane Biology45%
see_also📖FTLD-TDP Subtypes and Mechanisms45%
see_also📖Glial Tau Pathology in PSP and CBD45%
see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova45%
see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath45%
see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%
see_also📖Neuroresilience Mechanisms and Evidence45%
see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031045%
see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%
see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%
see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 45%
see_also📖Synaptic Loss and Dysfunction Pathway45%
see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality45%
related🔬What are the mechanisms underlying selective vulnerability o42%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp42%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬What are the mechanisms underlying rna binding protein dysre40%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Heat Shock Protein 70 Disaggregase Amplification40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub